Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 01:37:50 GMT 2023
by
admin
on
Sat Dec 16 01:37:50 GMT 2023
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG2 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
H18SKU3289
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
H18SKU3289
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
KK-166
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
DB12053
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
8054
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL2108811
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
VISILIZUMAB
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
SUB75525
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
219716-33-3
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY | |||
|
C2229
Created by
admin on Sat Dec 16 01:37:50 GMT 2023 , Edited by admin on Sat Dec 16 01:37:50 GMT 2023
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_134 | 3_213 |
| 1_147 | 1_203 |
| 1_222 | 2_222 |
| 1_223 | 2_223 |
| 1_226 | 2_226 |
| 1_229 | 2_229 |
| 1_260 | 1_320 |
| 1_366 | 1_424 |
| 2_22 | 2_96 |
| 2_134 | 4_213 |
| 2_147 | 2_203 |
| 2_260 | 2_320 |
| 2_366 | 2_424 |
| 3_23 | 3_87 |
| 3_133 | 3_193 |
| 4_23 | 4_87 |
| 4_133 | 4_193 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_296 |
| N | 2_296 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|